Canada Digital Therapeutics Market Analysis Report 2022 to 2030

Canada Digital Therapeutics Market Analysis

$ 3999

Canada Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.7 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period. The industry is being driven by advancements in technology, government support and regulations, and growing awareness. The market is dominated by key players like Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., HYGIEIA, BigHealth, and Voluntis.

ID: IN10CADH006 CATEGORY: Digital Health GEOGRAPHY: Canada AUTHOR: Aneri Parekh

Buy Now

Canada Digital Therapeutics Market Executive Summary

Canada Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.7 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period.

The Digital therapeutics market in Canada is the area of the healthcare business that uses digital technologies to provide evidence-based treatment plans. This industry includes a broad spectrum of software-driven products, like virtual platforms and mobile apps, intended to cure, manage, or prevent different medical diseases. The digital therapeutics market, which offers individualized and easily available therapies for better patient outcomes, is crucial in changing the traditional healthcare landscape as Canada adopts advancements in digital health.

The growing use of digital health solutions is propelling the strong growth of the Canadian digital therapeutics market. The industry is growing as a result of government programs promoting digital healthcare and growing public awareness of the advantages of digital therapies. Prominent industry participants are proactively pursuing innovation and working together to leverage the increasing need for digital treatments within Canada.

The digital therapeutics market has had a remarkable expansion, with global revenue of $6.2 Bn generated in 2023. This extraordinary expansion is evidence of the significant transformation the industry has seen as a result of the use of cutting-edge technology and economical production techniques. Digital therapies are therefore increasingly seen as crucial to the healthcare system. The market's trajectory indicates the possibility of further innovations, and it is expected that ongoing advancements will facilitate the market's ongoing growth and transformative impact on patient care.

Omada has formed significant alliances with Canadian companies such as Green Shield Canada and Sun Life to make their digital medicines programs available to insurers and employers. Through these collaborations, they increase their standing in the Canadian market. Omada's programs are in line with Canada's healthcare priorities by addressing common chronic diseases including prediabetes and diabetes. Over 0.1 Mn Canadians have benefited from Omada's Prevent program in preventing or delaying type 2 diabetes.

Canada digital therapeutics market

Market Dynamics

Market Growth Drivers:

Technological Developments: The efficacy and accessibility of digital treatments are improved by the continuous development of technology, which includes wearables, smartphone apps, and telehealth platforms.

Government Policy and Regulation: Promoting the adoption of digital therapies is greatly aided by favorable government policies, reimbursement plans, and regulatory frameworks.

Growing Awareness: The benefits of digital therapeutics in enhancing conventional treatments are becoming more widely known to patients and healthcare professionals, which is leading to market expansion.

Market Restraints:

Regulatory Difficulties: There may be regulatory ambiguities and obstacles for digital therapies. The requirement for unambiguous rules and regulations from health authorities may prevent the market from expanding.

Data Security and Privacy Issues: Patient data security and privacy become increasingly important as our reliance on digital technologies grows. Adoption may be hampered by worries about data breaches and illegal access to private medical records.

Lack of Standardization: Interoperability standards and established protocols for digital medicines are lacking, which could impede easy data sharing and collaboration between various healthcare providers and systems.

Healthcare Policies and Regulatory Landscape

Health Canada is the regulatory body that approves digital therapeutics' safety and efficacy. To respond to quick innovation cycles, adapt to constantly evolving digital health technologies, and provide a more focused pre-market evaluation of digital health technologies, Health Canada has created a new branch under the Therapeutic Products Directorate's Medical Devices Bureau. It might be difficult to prove the clinical efficacy of complicated digital treatments using typical randomized controlled trials (RCTs), especially when compared to physical devices. Furthermore, concerns regarding the collection and protection of user data within digital therapies are brought up by stringent data privacy legislation such as PIPEDA (Personal Information Protection and Electronic Documents Act).

Competitive Landscape

Key Players:

Omada Health Inc.
WellDoc Inc.
2Morrow Inc.
Livongo Health Inc.
Propeller Health
Canary Health
Noom Inc.
Akili Interactive Labs Inc.
HYGIEIA
BigHealth
Voluntis

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Digital Therapeutics Market Segmentation

By Solution

Software
Services

By Deployment

Cloud-based
On-premises

By Application

Therapy
Diabetes
Obesity
CNS
Respiratory
CVD

By End-use

Diagnostic Centres
Healthcare Players
Healthcare Research Centres
Hospitals & Clinics
Nursing Care Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.